How Best to Profile an Asset to Make Informed Decisions in the Beginning of a Commercial Strategy
Time: 3:00 pm
day: Conference Day Two
Details:
- Defining the target patient population utilizing epidemiology data and real-world evidence to refine market size and potential
- Aligning clinical development with commercial objectives ensuring trial endpoints support regulatory approval and payer negotiations
- Prioritizing key geographies and markets identifying regions with the highest unmet need, fastest regulatory pathways, and most favourable reimbursement environments to maximize commercial success
